In vitro acoustic characterisation of four intravenous ultrasonic contrast agents at 30 MHz

The acoustic properties of four ultrasonic contrast agents (Optison(TM), Definity(TM), SonoVue(TM) and Sonazoid(TM)) were studied at 30 MHz using a Boston Scientific ClearView Ultra intravascular ultrasound (US) scanner modified to allow access to the unprocessed US data. A range of contrast agent concentrations were studied using either saline or glucose as the diluent of choice. Mean backscatter power was measured over regions-of-interest (ROI) at distances of 1, 1.5, 2, 3, 4 and 5 mm from the centre of the intravascular probe and normalised to the US data collected from a standard glass reflector. For all of the agents, the mean backscatter power at 30 MHz varied in a linear manner with concentration between 0.01 million microbubbles/mL and 1 million microbubbles/mL. Furthermore, for two of the agents, mean backscatter enhancement was detectable at concentrations as low as 2 microbubbles/sample volume. (E-mail:carmel.moran@ed.ac.uk) (C) 2002 World Federation for Ultrasound in Medicine Biology.